Pattern of proinflammatory cytokine induction in RAW264.7 mouse macrophages is identical for virulent and attenuated Borrelia burgdorferi

Journal of Immunology

Volumn 180, Issue 12, 2008, Pages 8306-8315

  Wang, Guiqing ^a,b   Petzke, Mary M ^a   Iyer, Radha ^a   Wu, Hongyan ^b   Schwartz, Ira ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CHEMOKINE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BORRELIA BURGDORFERI; CONTROLLED STUDY; GENE EXPRESSION; LYME DISEASE; MACROPHAGE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SUPERNATANT; ANIMAL; BIOSYNTHESIS; C3H MOUSE; CELL LINE; COMPARATIVE STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIRULENCE;

ANIMALS; BORRELIA BURGDORFERI; CELL LINE; CHEMOKINES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; LYME DISEASE; MACROPHAGES; MALE; MICE; MICE, INBRED C3H; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC; VIRULENCE;

EID: 50949107248     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.12.8306     Document Type: Article

References (53)

1. Orlowski, K. A., E. B. Hayes, G. L. Campbell, and D. T. Dennis. 2000. Surveillance for Lyme disease: United States, 1992-1998. Morbid. Mortal. Wkly. Rep. CDC Surveill Summ. 49: 1-11.
2. Steere, A. C, R. L. Grodzicki, A. N. Komblatt, J. E. Craft, A. G. Barbour, W. Burgdorfer, G. P. Schmid, E. Johnson, and S. E. Malawista. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308: 733-740.
3. Steere, A. C, and V. K. Sikand. 2003. The presenting manifestations of Lyme disease and the outcomes of treatment. N. Engl. J. Med. 348: 2472-2474.
4. Salazar, J. C, C. D. Pope, T. J. Sellati, H. M. Feder, Jr., T. G. Kiely, K. R. Dardick, R. L. Buckman, M. W. Moore, M. J. Caimano, J. G. Pope, et al. 2003. Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J. Immunol. 171: 2660-2670.
5. Georgilis, K., A. C. Steere, and M. S. Klempner. 1991. Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. J. Infect. Dis. 163: 150-155.
6. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345: 115-125.
7. Livens, D., G. P. Wormser, J. Nowakowski, R. B. Nadelman, S. Bittker, D. Cooper, S. Varde, F. H. Moy, G. Forseter, C. S. Pavia, and I. Schwartz. 1996. Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis. J. Clin. Microbiol. 34: 1306-1309.
8. Livens, D., A. Gazumyan, and I. Schwartz. 1995. Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis. J. Clin. Microbiol. 33: 589-595.
9. Wormser, G. P., D. Livens, J. Nowakowski, R. B. Nadelman, L. F. Cavaliere, D. McKenna, D. Holmgren, and I. Schwartz. 1999. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J. Infect. Dis. 180: 720-725.
10. Wang, G., C. Ojaimi, R. Iyer, V. Saksenberg, S. A. McClain, G. P. Wormser, and I. Schwartz. 2001. Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HcJ mice. Infect. Immun. 69: 4303-4312.
11. Wang, G., C. Ojaimi, H. Wu, V. Saksenberg, R. Iyer, D. Livens, S. A. McClain, G. P. Wormser, and I. Schwartz. 2002. Disease severity in a murine model of Lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J. Infect. Dis. 186: 782-791.
12. Wooten, R. M., and J. J. Weis. 2001. Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr. Opin. Microbiol. 4: 274-279.
13. Ma, Y., K. P. Seiler, E. J. Eichwald, J. H. Weis, C. Teuscher, and J. J. Weis. 1998. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect. Immun. 66: I61-168.
14. Weis, J. J. 2002. Host-pathogen interactions and the pathogenesis of murine Lyme disease. Curr. Opin. Rheumatol. 14: 399-403.
15. Glickstein, L., B. Moore, T. Bledsoe, N. Damle, V. Sikand, and A. C. Steere. 2003. Inflammatory cytokine production predominates in early Lyme disease in patients with erythema migrans. Infect. Immun. 71: 6051-6053.
16. Oksi, J., J. Savolainen, J. Pene, J. Bousquet, P. Laippala, and M. K. Viljanen. 1996. Decreased interleukin-4 and increased γ interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis. Infect. Immun. 64: 3620-3623.
17. Widhe, M, S. Jarefors, C. Ekerfelt, M. Vrethem, S. Bergstrom, P. Forsberg, and J. Emerudh. 2004. Borrelia-specidc interferon-γ and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J. Infect. Dis. 189: 1881-1891.
18. Zeidner, N., M. Dreitz, D. Belasco, and D. Fish. 1996. Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-a, interleukin-2, and interferon-γ. J. Infect. Dis. 173: 187-195.
19. Zeidner, N., M. L. Mbow, M. Dolan, R. Massung, E. Baca, and J. Piesman. 1997. Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice. Infect. Immun. 65: 3100-3106.
20. Brown, J. P., J. F. Zachary, C. Teuscher, J. J. Weis, and R. M. Wooten. 1999. Dual role of interieukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect. Immun. 67: 5142-5150.
21. Gross, D. M., A. C. Steere, and B. T. Huber. 1998. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol. 160: 1022-1028.
22. Harjacek, M., S. Diaz-Cano, B. A. Alman, J. Cobum, R. Ruthazer, H. Wolfe, and A. C. Steere. 2000. Prominent expression of mRNA for proinflammatory cyto-kincs in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis. J. Rheumatol. 27: 497-503.
23. Armstrong, A. L., S. W. Barthold, D. H. Persing, and D. S. Beck. 1992. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 47: 249-258.
24. Ruderman, E. M., J. S. Kerr, S. R. Telford, III, A. Spielman, L. H. Glimcher, and E. M. Gravallese. 1995. Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4+ T cell interactions. J. Infect. Dis. 171: 362-370.
25. Montgomery, R. R., X. M. Wang, and S. E. Malawista. 2001. Murine Lyme disease: no evidence for active immune down-regulation in resolving or subclinical infection. J. Infect. Dis. 183: 1631-1637.
26. Brown, C. R., V. A. Blaho, and C. M. Loiacono. 2003. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J. Immunol. 171: 893-901.
27. Du Chateau, B. K., D. M. England, S. M. Callister, L. C. Lim, S. D. Lovrich, and R. F. Schell. 1996. Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters. Infect. Immun. 64: 2540-2547.
28. DuChateau, B. K., J. R. Jensen, D. M. England, S. M. Callister, S. D. Lovrich, ar R. F. Schell. 1997. Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis. Infect. Immun. 65: 2829-2836.
29. Ebnet, K., M. M. Simon, and S. Shaw. 1996. Regulation of chemokine gene expression in human endothelial cells by proinflammatory cytokines and Borrelia burgdorferi. Ann. NY Acad. Sci. 797: 107-117.
30. Habicht, G. S., G. Beck, J. L. Benach, J. L. Coleman, and K. D. Leichtling. 1985. Lyme disease spirochetes induce human and murine interleukin 1 production. J. Immunol. 134: 3147-3154.
31. Sprenger, H., A. Krause, A. Kaufmann, S. Priem, D. Fabian, G. R. Burmester, D. Gemsa, and M. G. Riltig. 1997. Borrelia burgdorferi induces chemokines in human monocytes. Infect. Immun. 65: 4384-4388.
32. Wooten, R. M., T. B. Morrison, J. H. Weis, S. D. Wright, R. Thieringer, and J. J. Weis. 1998. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol. 160: 5485-5492.
33. Crandall, H., D. M. Dunn, Y. Ma, R. M. Wooten, J. F. Zachary, J. H. Weis, R. B. Weiss, and J. J. Weis. 2006. Gene expression profiling reveals unique pathways associated with differential severity of Lyme arthritis. J. Immunol. 177: 7930-7942.
34. Ojaimi, C, C. Brooks, S. Casjens, P. Rosa, A. Elias, A. Barbour, A. Jasinskas, J. Benach, L. Katona, J. Radolf, et al. 2003. Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays. Infect. Immun. 71: 1689-1705.
35. Yang, Y. H., and T. Speed. 2003. Normalization. In DNA Microarrays, A Molecular Cloning Manual. D. Bowtell and J. Sambrook, eds. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 536-543.
36. Wang, G., Y. Ma, A. Buyuk, S. McCIain, J. J. Weis, and I. Schwartz. 2004. Impaired host defense to infection and Toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ mice. FEMS Microb. Lett. 231: 219-225.
37. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25: 402-408.
38. Ulevitch, R. J., and P. S. Tobias. 1999. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11: 19-22.
39. Miller, L. C, S. Isa, E. Vannier, K. Georgilis, A. C. Steere, and C. A. Dinarello. 1992. Live Borrelia burgdorferi preferentially activate interleukin-1 β gene expression and protein synthesis over the interleukin-1 receptor antagonist. J. Clin. Invest. 90: 906-912.
40. Miller, L. C, E. A. Lynch, S. Isa, J. W. Logan, C. A. Dinarello, and A. C. Steere. 1993. Balance of synovial fluid IL-1 β and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341: 146-148.
41. Rupprecht, T. A., H. W. Pfister, B. Angele, S. Kastenbauer, B. Wilske, and U. Koedel. 2005. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 65: 448-450.
42. Eberhard, Y., S. Ortiz, L. A. Ruiz, R. Kuznitzky, and H. M. Serra. 2004. Up-regulation of the chemokine CCL21 in the skin of subjects exposed to irritants. BMC Immunol. 5: 7-1.4.
43. Serra, H. M., Y. Eberhard, A. P. Martin, N. Gallino, J. Gagliardi, C. E. Baena-Cagnani, A. R. Lascano, S. Ortiz, A. L. Mariani, and M. Uguccioni. 2004. Secondary lymphoid tissue chemokine (CCL21) is upregulated in allergic contact dermatitis. Int. Arch. Allergy Immunol. 133: 64-71.
44. Diterich, I., L. Harter, D. Hassler, A. Wendel, and T. Hartung. 2001. Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients. Infect. Immun. 69: 687-694.
45. Straubinger, R. K., A. F. Straubinger, B. A. Summers, H. N. Erb, L. Harter, and M. J. Appel. 1998. Borrelia burgdorferi induces the production and release of proinflammatory cytokines in canine synovial explant cultures. Infect. Immun. 66: 247-258.
46. Giambartolomei, G. H., V. A. Dennis, B. L. Lasater, and M. T. Philipp. 1999. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect. Immun. 67: 140-147.
47. Murthy, P. K., V. A. Dennis, B. L. Lasater, and M. T. Philipp. 2000. Interleu-kin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-I stimulated with Borrelia burgdorferi lipoproteins. Infect. Immun. 68: 6663-6669.
48. Radolf, J. D., L. L. Amdt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154: 2866-2877.
49. Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis. 1999. Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163: 2382-2386.
50. Cabral, E. S., H. Gelderblom, R. L. Homung, P. J. Munson, R. Martin, and A. R. Marques. 2006. Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes. J. Infect. Dis. 193: 849-859.
51. Hu, L. T., M. A. Eskildsen, C. Masgala, A. C. Steere, E. C. Amer, M. A. Pratta, A. J. Grodzinsky, A. Loening, and G. Perides. 2001. Host metalloproteinases in Lyme arthritis. Arthritis Rheum. 44: 1401-1410.
52. Zhao, Z., H. Chang, R. P. Trevino, K. Whren, J. Bhawan, and M. S. Klempner. 2003. Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute Lyme disease. J. Infect. Dis. 188: 1098-1104.
53. Rosenberger, C. M., M. G. Scott, M. R. Gold, R. E. Hancock, and B. B. Finlay. 2000. Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J. Immunol. 164: 5894-5904.